Medrobotics manufactures and markets the Flex® Robotic System, the world’s first endoluminal robotic platform with a steerable and shapeable robotic scope. The Flex® Robotic System offers clinicians the unique ability to navigate complex anatomy with crystal clear 3D HD visualization through a single entry point. Once the target disease is accessed, the Flex® Robotic System provides a stable platform through which articulating flexible instruments are introduced providing consistent triangulation in hard-to-reach anatomical locations that might otherwise be inaccessible with traditional surgical instruments and difficult to treat with current endoscopic instruments. The company’s vision is to provide more patients with access to endoluminal treatment options. Medrobotics received FDA clearances for the Flex® Robotic System for ENT applications in July 2015 and for transanal applications in May 2017. The CE mark was issued in March 2014.
475 Paramount Drive
Raynham, Massachusetts 02767